๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Individualising netilmicin dosing in neonates

โœ Scribed by Catherine M. T. Sherwin; Roland S. Broadbent; Natalie J. Medlicott; David M. Reith

Publisher
Springer
Year
2008
Tongue
English
Weight
234 KB
Volume
64
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Individualised dosing of amikacin in neo
Individualised dosing of amikacin in neonates
โœ Catherine M. T. Sherwin; Roland S. Broadbent; Natalie J. Medlicott; David M. Rei ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Springer ๐ŸŒ English โš– 48 KB
Prediction of netilmicin disposition in
Prediction of netilmicin disposition in neonates
โœ M. Darwish; M. Batayneh; J. Jenkins; M. Scott; P. S. Collier; J. C. McElnay ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 656 KB

Multiple regression analyses of data from 33 neonates who received netilmicin therapy showed that concurrent treatment with other drugs (Drg), creatinine clearance (CL,,), gestational age (GA), and an apgar score of less than 6 at 1 min (Agl ') were significant determinants of netilmicin clearance.

Assessment of bioelectrical impedance fo
Assessment of bioelectrical impedance for individualising gentamicin therapy in neonates
โœ J. S. Sidhu; B. G. Charles; E. J. Triggs; D. I. Tudehope; P. H. Gray; P. A. Stee ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Springer ๐ŸŒ English โš– 678 KB

The use of bioelectrical impedance (BI) analysis as a non-invasive approach for individualizing gentamicin therapy in newborn infants has been investigated in a two phase study. In Phase I, 1/impedance and length were identified as statistically significant predictors of the distribution volume of g